Publications

  1. Boules MM, Fredrickson P, Muehlmann AM, Richelson E. Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. Behav Sci (Basel). 2014 Jun; 4(2):125-53. Epub 2014 Jun 13.
    View PubMed
  2. Fredrickson P, Boules M, Richelson E. Neurotensin agonists in the regulation of food intake. Int J Obes (Lond). 2014 Mar; 38(3):474. Epub 2013 Jul 17.
    View PubMed
  3. Fredrickson P, Boules M, Stennett B, Richelson E. Neurotensin agonist attenuates nicotine potentiation to cocaine sensitization. Behav Sci (Basel). 2014 Mar; 4(1):42-52. Epub 2014 Jan 22.
    View PubMed
  4. Boules M, Li Z, Smith K, Fredrickson P, Richelson E. Diverse roles of neurotensin agonists in the central nervous system. Front Endocrinol (Lausanne). 2013; 4:36. Epub 2013 Mar 22.
    View PubMed
  5. Blackshear JL, Safford R, Fredrickson P, Thomas C, Heckman M, Al-Omari M, Kaplan J. Scientific letter: A double-blind, randomised, placebo-controlled, 3-month crossover trial of night-time oxygen therapy in advanced systolic heart failure. Heart. 2012 Oct; 98(19):1468-9. Epub 2012 Aug 3
    View PubMed
  6. Spector AR, Dugger BN, Wszolek ZK, Uitti RJ, Fredrickson P, Kaplan J, Boeve BF, Dickson DW, Strongosky A, Lin SC. Anatomy of disturbed sleep in pallido-ponto-nigral degeneration. Ann Neurol. 2011 Jun; 69(6):1014-25.
    View PubMed
  7. Boules M, Oliveros A, Liang Y, Williams K, Shaw A, Robinson J, Fredrickson P, Richelson E. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats. Neuropeptides. 2011 Feb; 45(1):9-16. Epub 2010 Nov 02.
    View PubMed
  8. Arunthari V, Kaplan J, Fredrickson PA, Lin SC, Castillo PR, Heckman MG. Prevalence of restless legs syndrome in blood donors. Mov Disord. 2010 Jul 30; 25(10):1451-5.
    View PubMed
  9. Liang Y, Boules M, Shaw AM, Williams K, Fredrickson P, Richelson E. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain. Brain Res. 2008 Sep 22; 1231:6-15. Epub 2008 Jul 19.
    View PubMed
  10. Willis FB, Isley AL, Geda YE, Shaygan A, Quarles L 4th, Fredrickson PA. Resolution of syncope with treatment of sleep apnea. J Am Board Fam Med. 2008 Sep-Oct; 21(5):466-8.
    View PubMed
  11. Bendel RE, Kaplan J, Heckman M, Fredrickson PA, Lin SC. Prevalence of glaucoma in patients with obstructive sleep apnoea--a cross-sectional case-series. Eye (Lond). 2008 Sep; 22(9):1105-9. Epub 2007 May 04.
    View PubMed
  12. Ames SC, Patten CA, Werch CE, Schroeder DR, Stevens SR, Fredrickson PA, Echols JD, Pennebaker JW, Hurt RD. Expressive writing as a smoking cessation treatment adjunct for young adult smokers. Nicotine Tob Res. 2007 Feb; 9(2):185-94.
    View PubMed
  13. Boules M, Iversen I, Oliveros A, Shaw A, Williams K, Robinson J, Fredrickson P, Richelson E. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat. Brain Res. 2007 Jan 5; 1127(1):90-8. Epub 2006 Nov 17.
    View PubMed
  14. Boules M, Shaw A, Fredrickson P, Richelson E. Neurotensin agonists: potential in the treatment of schizophrenia. CNS Drugs. 2007; 21(1):13-23.
    View PubMed
  15. Boules M, Fredrickson P, Richelson E. Bioactive analogs of neurotensin: focus on CNS effects. Peptides. 2006 Oct; 27(10):2523-33. Epub 2006 Aug 01.
    View PubMed
  16. Castillo PR, Kaplan J, Lin SC, Fredrickson PA, Mahowald MW. Prevalence of restless legs syndrome among native South Americans residing in coastal and mountainous areas. Mayo Clin Proc. 2006 Oct; 81(10):1345-7.
    View PubMed
  17. Black JL 3rd, Silber MH, Krahn LE, Avula RK, Walker DL, Pankratz VS, Fredrickson PA, Slocumb NL. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy. Biol Psychiatry. 2005 Sep 15; 58(6):504-9.
    View PubMed
  18. Fredrickson P, Boules M, Lin SC, Richelson E. Neurobiologic basis of nicotine addiction and psychostimulant abuse: a role for neurotensin? Psychiatr Clin North Am. 2005 Sep; 28(3):737-51, 746.
    View PubMed
  19. Boules M, Fredrickson P, Richelson E. Neurotensin agonists as an alternative to antipsychotics. Expert Opin Investig Drugs. 2005 Apr; 14(4):359-69.
    View PubMed
  20. Black JL 3rd, Silber MH, Krahn LE, Fredrickson PA, Pankratz VS, Avula R, Walker DL, Slocumb NL. Analysis of hypocretin (orexin) antibodies in patients with narcolepsy. Sleep. 2005 Apr; 28(4):427-31.
    View PubMed
  21. Boues M, Fredrickson P, Richelson E. Current topics: brain penetrating neurotensin analog. Life Sci. 2003 Oct 17; 73(22):2785-92.
    View PubMed
  22. Fredrickson P, Boules M, Yerbury S, Richelson E. Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization. Brain Res. 2003 Jul 25; 979(1-2):245-8.
    View PubMed
  23. Richelson E, Boules M, Fredrickson P. Neurotensin agonists: possible drugs for treatment of psychostimulant abuse. Life Sci. 2003 Jun 27; 73(6):679-90.
    View PubMed
  24. Fredrickson P, Boules M, Yerbury S, Richelson E. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. Eur J Pharmacol. 2003 Jan 1; 458(1-2):111-8.
    View PubMed
  25. Becker PM, Jamieson AO, Jewel CE, Bogan RK, James DS, Sutton JT, Corser B, Mayleben DW, Bernard SH, Dinner DS, Emsellem H, Knight E, Erwin CW, Krystal AD, Radtke RA, Farrow S, Odynski T, Pinto J, Steljes D, Feldman NT, O'Brien M, Fredrickson PA, Kaplan J, Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology. 2000 Mar 14; 54(5):1166-1175.
    View PubMed
  26. Dinges D, Ball E, Fredrickson P, Kiley J, Kryger MH, Richardson GS, Rogus S, Sheldon S, Wooten V, Zepf B. Recognizing problem sleepiness in your patients. Am Fam Physician. 1999 Feb 15; 59(4):937-944.
    View PubMed
  27. Lin SC, Kaplan J, Burger CD, Fredrickson PA. Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin Proc. 1998 Jun; 73(6):497-500.
    View PubMed
  28. Mitler MM, Guilleminault C, Harsh JR, Hirshkowitz M, Fredrickson PA, Kaplan J. U.S. Modafinil in Narcolepsy Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Annals of Neurology 43:88-97, 1998.
  29. Fredrickson PA, Hurt RD, Lee GM, Wingender L, Croghan IT, Lauger G, Gomez-Dahl L, Offord KP. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology (Berl). 1995 Dec; 122(3):215-22.
    View PubMed
  30. Loui WS, Blackshear JL, Fredrickson PA, Kaplan J. Obstructive sleep apnea manifesting as suspected angina: report of three cases. Mayo Clin Proc. 1994 Mar; 69(3):244-8.
    View PubMed
  31. Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, Lauger GG, Marusic Z, Neese LW, Lundberg TG. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA. 1994 Feb 23; 271(8):595-600.
    View PubMed
  32. Kaplan J, Fredrickson PA, Renaux SA, O'Brien PC. Theophylline effect on sleep in normal subjects. Chest. 1993 Jan; 103(1):193-5.
    View PubMed
  33. Juergens SM, Hurt RD, Offord KP, Zarling KK, Zemke KK, Anderson LL, Fredrickson PA, Miller FA Jr. Alcoholism in a coronary care unit population. J Addict Dis. 1993; 12(2):57-76.
    View PubMed
  34. Thorpy M, Westbrook P, Ferber R, Fredrickson P, Mahowald M, Perez-Guerra F, Reite M, Smith P. The clinical use of the multiple sleep latency test. Sleep. 1992; 15(3):268-76.
    View PubMed
  35. Mahowald M, Ferber R, Fredrickson P, Perez-Guerra F, Reite M, Smith P, Thorpy M, Westbrook P. Assessment: Techniques associated with the diagnosis and management of sleep disorders. Neurology. 1992; 42:269-74.
    View PubMed
  36. Fredrickson P. Insomnia in primary care medicine. Position paper prepared for the National Commission on Sleep Disorders Research, Wake Up America: A National Sleep Alert-Report of the National Commission on Sleep Disorders Research, Department of Health and Human Services, Washington, D.C.: Superintende nt of Documents, U.S. Government Printing Office,1992.
  37. Kaplan J, Fredrickson PA, Richardson JW. Sleep and breathing in patients with the Prader-Willi syndrome. Mayo Clin Proc. 1991 Nov; 66(11):1124-6.
    View PubMed
  38. Richardson JW, Fredrickson PA, Lin SC. Narcolepsy update. Mayo Clin Proc. 1990 Jul; 65(7):991-8.
    View PubMed
  39. Fredrickson PA, Richardson JW, Esther MS, Lin SC. Sleep disorders in psychiatric practice. Mayo Clin Proc. 1990 Jun; 65(6):861-8.
    View PubMed
  40. Fredrickson PA, Kaplan J, Richardson JW, et al. Prevalence of alcohol abuse in narcolepsy and other disorders of excessive somnolence. Archives of the Foundation of Thanatology. 1989; 16:113-4.
  41. Fredrickson PA. The relevance of sleep disorders medicine to psychiatric practice. Psychiatr Ann. 1987 Feb; 17:91-5, 99-100.
  42. Juergens SM, Fredrickson PA, Pfeiffer FE. Balint's syndrome mistaken for visual conversion reaction. Psychosomatics. 1986 Aug; 27(8):597-9.
    View PubMed
  43. Flavin DK, Fredrickson PA, Richardson JW, Merritt TC. Corticosteroid abuse--an unusual manifestation of drug dependence. Mayo Clin Proc. 1983 Nov; 58(11):764-6.
    View PubMed
  44. Fredrickson P, Richelson E. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review. J Clin Psychiatry. 1979 Sep; 40(9):399-405.
    View PubMed
  45. Fredrickson PA, Richelson E. Hallucinogens antagonize histamine H1 receptors of cultured mouse neuroblastoma cells. Eur J Pharmacol. 1979 Jun 15; 56(3):261-4.
    View PubMed